Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer-Reference-Cited by-同舟云学术

Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer

Published:2018-10-05 Issue:12 Volume:35 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Mehra Rohit^ORCID,Salami Simpa S.,Lonigro Robert,Bhalla Ritu,Siddiqui Javed,Cao Xuhong,Spratt Daniel E.,Palapattu Ganesh S.,Palanisamy Nallasivam,Wei John T.,Chinnaiyan Arul M.,Tomlins Scott A.

Funder

National Institute of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s12032-018-1212-6/fulltext.html

Reference42 articles.

1. Roychowdhury S, Iyer MK, Robinson DR, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med. 2011;3:111ra121–1. https://doi.org/10.1126/scitranslmed.3003161 .

2. Jiang B-H, Liu L-Z. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta. 2008;1784:150–8. https://doi.org/10.1016/j.bbapap.2007.09.008 .

3. Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127–50. https://doi.org/10.1146/annurev.pathol.4.110807.092311 .

4. Morgan TM, Koreckij TD, Corey E. Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets. 2009;9:237–49.

5. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–8. https://doi.org/10.1126/science.1117679 .

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomy;Archivio Italiano di Urologia e Andrologia;2022-12-27

2. Tumour microenvironment and focal therapy for prostate cancer;Current Opinion in Urology;2022-05

3. Prognostic Significance of PD-L1 and PTEN Expression in Prostatic Cancer;MIDDLE EAST J CANCER;2022

4. Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies;The Journal of Molecular Diagnostics;2021-08

5. Transcriptional landscape of PTEN loss in primary prostate cancer;BMC Cancer;2021-07-26